ZM-007

**ZM-007** is an investigational veterinary oral suspension formulation of **metronidazole**, an anti-infective antibiotic, developed specifically for treating acute diarrhea in dogs, particularly smaller breeds and puppies under 9 pounds (4 kg). It addresses the need for accurate dosing in these patients, reducing reliance on compounded human formulations or large tablets like ZM-012, its tablet counterpart. Developed by **Zomedica**, ZM-007 underwent an Investigational New Animal Drug (INAD) application with the FDA Center for Veterinary Medicine in 2016 to validate its safety and efficacy for canine use, as metronidazole lacks FDA-CVM approval for veterinary applications despite common off-label use.[1][3][7][9]

Other names

ZM-007 metronidazole oral suspensionZM007 metronidazole oral suspensionZM 007 metronidazole oral suspension